Relative lung bioavailability of generic sodium cromoglycate inhalers used with and without a spacer device

Pulmonary Pharmacology and Therapeutics

Volumn 14, Issue 2, 2001, Pages 129-133

  Aswania, O ^a   Chrystyn, H ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Breath actuated inhaler; Metered dose inhaler; Relative lung deposition; Sodium cromoglycate; Spacer; Urinary excretion

Indexed keywords

CROMOGLYCATE DISODIUM;

ADULT; ARTICLE; DOSE TIME EFFECT RELATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EXCRETION; FEMALE; HUMAN; MALE; METERED DOSE INHALER; NORMAL HUMAN; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0034973777     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.2001.0279     Document Type: Article

References (18)

1. Use of pressurised aerosols by asthmatic patients
2. Survey of the clinical use of pressurised aerosol inhalers
3. Problems patients have using pressurised aerosol inhalers
4. Errors in inhalation technique and efficiency in inhaler use in asthmatic children
5. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique
6. A small volume spacer for use with a breath-operated pressurised metered dose inhaler
7. The use of a new breath-actuated inhaler by patients with sever airway obstruction
8. Aerosol deposition in the human lung following administration from a microprocessor controlled pressurised metered dose inhaler
9. Relative bioavailability of sodium cromoglycate to the lung following inhalation, using urinary excretion
10. Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung
11. Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation and avoiding multiple actuations of drug
12. Development and validation of an ion-pair chromatographic method for the quantitation of sodium cromoglycate in urine, following inhalation
13. Relative deposition characteristics of sodium cromoglycate following inhalation from different products
14. In vitro performance of plastic spacer devices
15. Determination of the relative bioavailability of salbutamol to the lung following inhalation
16. Determination of the relative bioavailability of nedocromil sodium to the lung following inhalation using urinary excretion
17. Is total particle dose more important then particle distribution